RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.

Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including TwitterLinkedIn and Facebook.

Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.

New EU regulatory changes are coming: Here’s what you need to know
by Fink Densford, Medical Design & Outsourcing, 2 January 2019
HHS Recommends Co-Prescribing Naloxone With Opioids
by  Joyce Frieden,  Medpage Today, 20 December 2018

Medtech Losers of 2018
by  MDDI Staff,  Medical Device and Diagnostics Industry, 19 December 2018

Waiting in the shadow of a no deal Brexit
Manufacturing Chemist, 19 December 2018

MDR: Market disruption on the horizon
MedTech Engine​, 11 December 2018

FDA Approves NIH-Funded Genetic Database, Issues Draft Guidance on NASH
Pharmacy Choice, 7 December 2018

Disruption of the Year: EU regulatory overhaul
by  Meg Bryant,  MedTechDive, 3 December 2018